Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan-Feb;10(1):89-100.

Determining factors for Cannabis use among Moroccans Schizophrenic Patients: A cross sectional study

Sara Bouri  1 , Hanane Hanane  2 , Khadija El Ayoubi Idrissi  2 , Mohamed Amine Berraho  3 , Abdelfattah Abdellaoui  1 , Lyoussi Badiaa  1 , Ismail Rammouz  2 , Sanae Achour  4
Affiliations

Determining factors for Cannabis use among Moroccans Schizophrenic Patients: A cross sectional study

Sara Bouri et al. Avicenna J Phytomed. 2020 Jan-Feb.

Abstract

Objective: Cannabis use is considered a major clinical problem associated with a poorer outcome in patients with schizophrenia. The objective of the present study was to assess the prevalence of cannabis us among patients with schizophrenia. The assessment consists in comparing some factors related to substance use in a population of schizophrenic patients between cannabis users and non.

Materials and methods: Four hundred and three participants who were examined prospectively during their hospitalization answered the PANNS scale of schizophrenia, GAF, BIS-10, CDSS, and MARS. The consumption of cannabis was investigated using urine toxicological analysis. Sociodemographic, clinical and therapeutic data were also recorded.

Results: The prevalence of cannabis use among schizophrenic inpatients was 49%. Patients with cannabis use were younger (31.7 vs 34.9 years old, p<0.001), more often male (52 vs 20% female, p<0.001), and they presented more often a history of imprisonment (68.8% vs 31.2%, p<0.001). Patients who were users of cannabis had a lower age at onset of the disease than non-users (23.6 vs 24.8 years, p=0.029), and more often with poor medication adherence (p=0.001). Logistic regression revealed that factors associated with cannabis use among schizophrenics were the age, gender, history of imprisonment and poor medication adherence.

Conclusion: The study showed that a high prevalence of cannabis use among patients with schizophrenia which was associated with negative overall outcomes. Determining comorbid substance use disorders among schizophrenic patients is crucial as it may contribute to establish a better therapeutic strategy.

Keywords: Cannabis; Comorbidity; Prevalence; Schizophrenia; Toxicological analysis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that there is no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV-TR 2ndéd. Paris: Masson; 2003.
    1. Arndt S, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med. 1992;22:379–388. - PubMed
    1. Bessa MA, Mitsuhiro SS, Chalem E, Barros MM, Guinsburg R, Laranjeira R. Underreporting of use of cocaine and marijuana during the third trimester of gestation among pregnant adolescents. Addict Behav. 2010;35:266–269. - PubMed
    1. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res. 2001;48:69–82. - PubMed
    1. Carey KB, Carey MP, Chandra PS. Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India. J Clin Psychiat. 2003;64:767–774. - PMC - PubMed

LinkOut - more resources